Data / Form D filings / TETmedical, Inc.
TETmedical, Inc.: Form D filings
TETmedical, Inc., a biotechnology company in Fair Haven, NJ, filed 2 Form D notices with the SEC between 2023 and 2026. The latest, on June 24, 2026, reports $3.5 million sold of a $9.8 million offering to 45 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 71 RIVERLAWN DRIVE, Fair Haven, NJ, 07704
- Phone
- (732) 567-5300
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1980705
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 24, 2026 | New notice | $9,812,108 | $3,533,611 | $6,278,497 | 45 | Jun 12, 2026 | sec.gov |
| Jun 13, 2023 | New notice | $3,564,510 | $2,461,986 | $1,102,524 | 70 | May 31, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David Fischell | Executive Officer, Director | |
| Alex Travis | Executive Officer, Director | |
| Roy Cohen | Executive Officer | |
| Christine Bunt | Director | |
| John Conley | Director |
Other biotechnology companies in New Jersey that filed recently
- Ensho Therapeutics, Inc. $7.3 million · Oct 15, 2026
- Xenon Ophthalmics Inc $3.3 million · Oct 6, 2026
- LISATA THERAPEUTICS, INC. $351.9 million · Oct 2, 2026
- Bullseye Biodevices, Inc. $1.3 million · Aug 10, 2026
- Hepion Pharmaceuticals, Inc. $3.1 million · Aug 5, 2026
Every Form D from the week of Jun 22, 2026 · All recent filings in New Jersey · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what TETmedical, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.